"10.1371_journal.pone.0072232","plos one","2013-08-21T00:00:00Z","Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye","Carolinas Medical Center, University of North Carolina School of Medicineâ€“Charlotte Campus, Charlotte, North Carolina, United States of America; Baylor University Medical Center, Dallas, Texas, United States of America; International Brain Research Foundation, Flanders, New Jersey, United States of America; Neurologique, Ponte Vedra Beach, Florida, United States of America; Avanir Pharmaceuticals, Inc., Aliso Viejo, California, United States of America","Conceived and designed the experiments: RK JF. Analyzed the data: BB DC JF DK RK. Wrote the paper: BB DC JF DK RK. Investigators in the study: DC DK BB.","Funding for the PRISM study and editorial support for manuscript preparation were provided by Avanir Pharmaceuticals, Inc. Other potential conflicts of interest are as follows: Dr. Brooks has received funding and/or research grants from Biogen Idec, Avanir Pharmaceuticals, Inc., Acorda, Cytokinetics, GlaxoSmithKline Pharmaceuticals, Neuraltus Pharmaceuticals, NINDS Clinical Research Consortium, Synapse; Dr. Crumpacker has served on a scientific advisory board for and received speaking fees from Avanir Pharmaceuticals, Inc., and has received speaking fees from Accera and Novartis; Dr. Fellus has received a research grant and consulting fees from, has served on the Speakers Bureau for, and is a stockholder of Avanir Pharmaceuticals, Inc.; Dr. Kantor has received consulting fees from Avanir Pharmaceuticals, Inc.; Dr. Kaye is an employee and stockholder of Avanir Pharmaceuticals, Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Benjamin Rix Brooks","BRB",5,TRUE,2,NA,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
